L M. Eskens
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
As series of success stories; the pitfall of preoperative chemotherapy in unresectable carcinoma of the colon
Journal: Nederlands tijdschrift voor geneeskunde
Published: August 05, 2020
A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: June 29, 2020
Tivozanib: a new treatment option for renal cell carcinoma.
Journal: Drugs of today (Barcelona, Spain : 1998)
Published: February 17, 2018
Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics.
Journal: The pharmacogenomics journal
Published: January 25, 2015
Histological and Molecular Subclassification of Pancreatic and Nonpancreatic Periampullary Cancers: Implications for (Neo) Adjuvant Systemic Treatment.
Journal: Annals of surgical oncology
Published: October 21, 2014
Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapy.
Journal: The Netherlands journal of medicine
Published: October 17, 2014
Impact of pazopanib on docetaxel exposure: results of a phase I combination study with two different docetaxel schedules.
Journal: Cancer chemotherapy and pharmacology
Published: October 06, 2014
A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours.
Journal: British journal of cancer
Published: October 30, 2013
Pazopanib exposure decreases as a result of an ifosfamide-dependent drug-drug interaction: results of a phase I study.
Journal: British journal of cancer
Published: August 06, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026